 |
인쇄하기
취소
|
Binex filed IND for a new colon cancer drug.
Binex (President: Lee Baek-cheon) announced that an investigational new drug application (IND) for DC-Vac/IR, a new colon cancer injectable drug, was submitted to KFDA on March 2.
DE-Vac/IR is a new immunological agent for the colon cancer treatment by injecting auto-immunized cells into the tumors to stimulate cell's apoptosis after exposing radiation. The immunized cells were cultivated w...
DE-Vac/IR is a new immunological agent for the colon cancer treatment by injecting auto-immunized cells into the tumors to stimulate cell's apoptosis after exposing radiation. The immunized cells were cultivated w...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.